Should You Ignore Rocket Lab Stock? Why SpaceX May Be the Better Space Stock Today.

Rocket Lab (RKLB) stock retraced from an intraday high above $86 mid-month to just over $64 by late August, despite recent catalysts including a 93rd successful Electron launch and a $12M U.S. Space Force award for the Space Data Network Backbone. The article argues investors are rotating toward SpaceX (SPCX up ~30% in August) due to a much larger and more scalable launch and satellite/defense roadmap, while Rocket Lab’s Neutron remains delayed with no launches yet in 2026.

Analysis

The market is pricing this as a winner-take-most platform story, not a “more launches = more value” story. That is the key mechanism hurting RKLB: small launch success is necessary but not sufficient when the dominant competitor can bundle launch, connectivity, and defense applications into one ecosystem, which pushes the industry toward lower standalone launch margins and higher customer concentration. In that framework, RKLB’s government awards are useful for backlog, but they do not re-rate the equity unless they translate into recurring, high-ROIC revenue rather than incremental credibility.

The biggest second-order effect is on capital allocation. If RKLB remains forced to spend heavily on Neutron while the market gives it credit for SpaceX-like economics, the stock can de-rate quickly once investors refocus on dilution risk, launch cadence slippage, and the probability that any “transformative” acquisition simply adds integration complexity before adding durable cash flow. By contrast, the private/secondary SpaceX proxy is the cleaner expression of the theme because the structural winner is the one that can pressure both launch pricing and adjacent satellite services over the next 6-18 months.

Contrarian view: consensus is probably underestimating how much of RKLB’s recent strength is narrative-driven and overestimating how much of SpaceX’s lead can be closed with a few operational wins. The inflection point to watch is not another successful Electron launch; it is proof of Neutron flight cadence and gross margin trajectory after that. If Neutron slips again or if capital intensity rises faster than backlog, the multiple compression can happen in weeks, not years.

Key Decisions for Investors

• Short RKLB on strength or via call spreads after any narrative-led spike; use the prior highs as a reference stop only if Neutron gets a hard launch date and funded backlog visibly inflects.
• If SPCX is accessible through secondary/private channels, prefer SPCX exposure over RKLB for a 6-18 month horizon; it is the cleaner expression of launch + comms + defense monetization.
• Treat IRDM as an event-driven watch item, not a blind long: only get constructive if the acquisition terms preserve dilution discipline and the combined entity shows a credible path to FCF positive within 2-4 quarters.
• Set a thesis-falsifier alert on Neutron: any further launch delay or cost-overrun commentary should be used to add to the RKLB short; a successful first flight with repeatability is the main risk to the trade.
• Pair trade idea if liquidity allows: long a diversified aerospace/defense basket versus short RKLB, to isolate execution risk from the broader sector beta.